Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Hugo Campos is a man on a mission. He wants access to the data being collected inside his body by an implanted cardiac defibrillator. He believes that having this information could help him take control of his health—for example, by helping him figure out what triggers his frequent attacks of abnormal heart rhythms. While not life-threatening, they cause dizziness, fainting, and chest pain. But he says device makers are reluctant to make that information available, mostly for commercial reasons.

“I have this complex little computer implanted in my body, but I have no access to it,” says Campos. “The best that patients can do is get a printout of the report given to the doctor, and that’s designed for doctors, not patients. Patients are left in the dark.”

Campos’s goal is a new twist on the concept of open access, one that has emerged as implanted medical devices become more common and patients increasingly use wireless devices and smart-phone tools to track their health and take control of their care.

Campos was diagnosed with hypertrophic cardiac myopathy, a muscle thickening that makes it harder for the heart to pump blood, after passing out on a train platform several years ago. In November 2007, doctors implanted the defibrillator, a battery-powered device that monitors heart rhythm and delivers an electric shock to regulate it if needed.

These devices continually collect data on such metrics as heart rhythm, variations in impedance in the chest—an indicator of fluid build-up in the heart—battery life, and the time it takes to deliver a shock.

Cardiologist Eric Topol, director of the Scripps Translational Science Institute, says giving defibrillator patients access to their data is an excellent idea. “It could be an option for those individuals who want to learn about what triggers their arrhythmias,” he says. “The data would be helpful in resolving whether their symptoms, such as light-headedness or dizziness, were correlated in any way with an abnormal heart rhythm.”

By tracking episodes of light-headedness with a smart-phone app, Campos has discovered that scotch and caffeine appear to trigger his own abnormal rhythms. But detailed data on his heart activity might make that analysis much more accurate.

Campos, who talked about his efforts at a TEDx conference in Cambridge on Saturday, has approached both device makers and the U.S. Food and Drug Administration to try to get access to the data. But manufacturers have told him that the device is implanted to deliver therapy, not to provide information to the patient. And doing so is not part of their business model. He believes that because device makers see their primary market as physicians rather than patients, they are less motivated to make this information available to the people who actually live with the devices in their bodies. Another obstacle to open access, he adds, is that the information is incredibly valuable.

1 comment. Share your thoughts »

Credit: Hugo Campos

Tagged: Biomedicine, data, medical implants, hardware hacks, open access

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me